DIN 02422530 — ETOPOSIDE INJECTION, USP 20 MG
ETOPOSIDE INJECTION, USP is a solution of Etoposide marketed by STRIDES PHARMA CANADA INC. The full Etoposide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02422530
- Brand name
- ETOPOSIDE INJECTION, USP
- Active ingredient
- Etoposide
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STRIDES PHARMA CANADA INC
- Health Canada status
- DORMANT
- Drug class
- Topoisomerase II inhibitor (antineoplastic agent, podophyllotoxin derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Etoposide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02080036 | ETOPOSIDE INJECTION | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02239961 | ETOPOSIDE INJECTION | 20 MG | LIQUID | FRESENIUS KABI CANADA LTD | DORMANT |
| 02552671 | ETOPOSIDE INJECTION | 20 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 00616192 | VEPESID | 50 MG | CAPSULE | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |